News Announcement from the Chair of the Cell Therapies Board The Board of Directors of Cell Therapies Pty Ltd is delighted to announce that Ms. Michelle…Cell TherapiesOctober 13, 2021
News Protecting your cell therapy trial by building resilience in your supply chain Supply chain complexity has always been a factor in healthcare. Drugs are often time- or…Cell TherapiesSeptember 7, 2021
News The fast path to first-in-human cell therapy trials The development of cell and gene therapies (CGT) holds enormous promise for treating many different…Cell TherapiesSeptember 6, 2021
News Cell Therapies Pty Ltd facility accredited by the Ministry of Health, Labour and Welfare in Japan Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the…Cell TherapiesJune 21, 2021
News ISO certifications accredited to Cell Therapies Pty Ltd management systems Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the…Cell TherapiesApril 30, 2021
News Mr Peter Giannopoulos appointed as CEO of Cell Therapies Pty Ltd Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the…Cell TherapiesApril 6, 2021
News “INDUSTRY OF THE FUTURE”: A/Prof Dominic Wall talks onshore CAR-T manufacturing at Parliament House in Canberra Cell Therapies Pty Ltd interim CEO and Chief Scientific Officer A/Prof Dominic Wall has spoken…Cell TherapiesMarch 5, 2021
News VIDEO: Novartis and Cell Therapies CAR-T Manufacturing Announcement Last week we announced the TGA approval for Cell Therapies to manufacture Novartis’ CAR-T therapy,…Cell TherapiesFebruary 18, 2021
News TGA approves Cell Therapies Pty Ltd as the first Australian commercial CAR-T manufacturing site Cell Therapies Pty Ltd, a contract manufacturing organisation located within the Peter MacCallum Cancer Centre,…Cell TherapiesFebruary 11, 2021
News Dr. Dawn Driscoll stepping down as Cell Therapies CEO The Board of Cell Therapies Pty Ltd (CTPL) has announced that Dr Dawn Driscoll will…Cell TherapiesNovember 11, 2020